Model Re-Estimation: An Alternative for Poor Predictive Performance during External Evaluations? Example of Gentamicin in Critically Ill Patients
Background: An external evaluation is crucial before clinical applications; however, only a few gentamicin population pharmacokinetic (PopPK) models for critically ill patients included it in the model development. In this study, we aimed to evaluate gentamicin PopPK models developed for critically...
Saved in:
Main Authors: | Alexandre Duong (Author), Chantale Simard (Author), David Williamson (Author), Amélie Marsot (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aminoglycosides in the Intensive Care Unit: What Is New in Population PK Modeling?
by: Alexandre Duong, et al.
Published: (2021) -
Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
by: He S, et al.
Published: (2022) -
Estimation of thyroid function in critical illness: To be or not to be is the question
by: Vinayak Patki
Published: (2022) -
Pharmacokinetic Variability in Pediatrics and Intensive Care: Toward a Personalized Dosing Approach
by: Amélie Marsot
Published: (2018) -
Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?
by: Amélie Marsot
Published: (2020)